Primary Menu

The U.S. Food and Drug Administration is expected to authorize Pfizer’s COVID-19 vaccine for kids ages 12 to 15 by next week, setting up shots for many before the beginning of the next school year. That’s according to a federal official and a person familiar with the process. The FDA action would be followed by a meeting of a federal vaccine advisory committee to discuss whether to recommend the shot for 12- to 15-year-olds. Then the Centers for Disease Control and Prevention would act on the committee’s recommendation. Those steps could be completed in a matter of days.